BioAdaptives confirms first orders for XcellaraHeart, details debt and share progress
BioAdaptives says initial XcellaraHeart orders ship next week and mark the commercial launch of its Xcellara cellular wellness platform. It targets XcellaraResilience for October and says it has retired major convertible debt and 43.25M insider shares.
BioAdaptives said initial XcellaraHeart orders will ship next week, marking the commercial launch of the Xcellara cellular wellness platform. The company said XcellaraResilience is being prepared for an October launch and highlighted the retirement of major convertible debt and 43.25M insider shares.